- Home
- ZNTL vs ACNT Comparison
ZNTL vs ACNT Comparison
Compare ZNTL & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | ACNT |
|---|---|---|
| Founded | 2014 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 118.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | ACNT |
|---|---|---|
| Price | $1.41 | $15.09 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 554.4K | 100.3K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $26,865,000.00 | ★ $171,413,000.00 |
| Revenue This Year | N/A | $22.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $159.28 |
| Revenue Growth | N/A | ★ 65.05 |
| 52 Week Low | $1.01 | $10.76 |
| 52 Week High | $4.00 | $15.60 |
Technical Indicators
Market Signals| Indicator | ZNTL | ACNT |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 68.62 |
| Support Level | $1.31 | $14.52 |
| Resistance Level | $1.39 | $15.60 |
| Average True Range (ATR) | 0.07 | 0.55 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 66.67 | 74.59 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ACNT Ascent Industries Co.
Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.